The association of COVID-19 occurrence and severity with the use of angiotensin converting enzyme inhibitors or angiotensin-II receptor blockers in patients with hypertension.

The association of COVID-19 occurrence and severity with the use of angiotensin converting enzyme inhibitors or angiotensin-II receptor blockers in patients with hypertension.

<h4>Background</h4>A number of studies have reported the association between the use of angiotensin-converting enzyme inhibitor (ACEI) and angiotensin-II receptor blocker (ARB) medications and the occurrence or severity of coronavirus disease 2019 (COVID-19). Published results are inconc...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Mingfei Li, Ying Wang, Ndindam Ndiwane, Michelle B Orner, Natalia Palacios, Brant Mittler, Dan Berlowitz, Lewis E Kazis, Weiming Xia
Formato: Artículo
Lenguaje:inglés
Publicado: Public Library of Science (PLoS) 2021-01-01
Colección:PLoS ONE
Acceso en línea:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0248652&type=printable
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
Entrar Para información de reservas y retiradas

Internet

https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0248652&type=printable

Ejemplares similares